Form 8-K - Current report:
SEC Accession No. 0001193125-25-136297
Filing Date
2025-06-06
Accepted
2025-06-06 07:00:21
Documents
13
Period of Report
2025-06-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901981d8k.htm   iXBRL 8-K 27879
2 EX-16.1 d901981dex161.htm EX-16.1 1633
  Complete submission text file 0001193125-25-136297.txt   149383

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA calc-20250603.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20250603_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20250603_pre.xml EX-101.PRE 11725
16 EXTRACTED XBRL INSTANCE DOCUMENT d901981d8k_htm.xml XML 3806
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 251028857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)